ArticleFrontiers in oncology2025
Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prediction of myelosuppression in cervical cancer after concurrent chemoradiotherapy by CT radiomics-based model.BMC medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives: Acute radiation hematologic toxicity may disturb the radiotherapy plan and thus decrease the treatment outcome. However, whether the dose map has enough prediction value for detecting hematologic toxicity (HT) is still unknown. Methods: In this study, the pre-treatment CT images and the in-treatment dose map were collected from a discovery dataset of 299 patients and a validation dataset of 65 patients from another center. Then, the radiomic features of the clinical target volume (CTV) in the radiotherapy were extracted, and the least absolute shrinkage and selection operator (LASSO) algorithm was used for feature dimension deduction; three classifiers, that is, support vector machine (SVM) (rbf kernel), random forest, and CatBoost, were used to construct the HT classification model in rectal cancer patients. The model performance was evaluated by both the internal 20% dataset and the external multicenter dataset. Results: The results revealed that CatBoost achieved the best model performance in almost all tasks and that CT images performed similarly with the dose map, although their combination model performed lower. In addition, gender, age, and some radiomic features from the decomposed image space were the most representative features for HT prediction. Conclusion: Our study can confirm that the HT occurrence in locally advanced rectal cancer (LARC) patients was multifactorial, and combining effective features together can classify the high-risk patients with HT, thus timely preventing or detecting HT to improve the subsequent outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.